KR101039110B1 - A water composition comprising Broussonetia kazinoki Sieb. for immunopotentiating - Google Patents

A water composition comprising Broussonetia kazinoki Sieb. for immunopotentiating Download PDF

Info

Publication number
KR101039110B1
KR101039110B1 KR1020080088388A KR20080088388A KR101039110B1 KR 101039110 B1 KR101039110 B1 KR 101039110B1 KR 1020080088388 A KR1020080088388 A KR 1020080088388A KR 20080088388 A KR20080088388 A KR 20080088388A KR 101039110 B1 KR101039110 B1 KR 101039110B1
Authority
KR
South Korea
Prior art keywords
present
mulberry
water extract
immune function
extract
Prior art date
Application number
KR1020080088388A
Other languages
Korean (ko)
Other versions
KR20100029559A (en
Inventor
신현규
하혜경
이호영
정다영
이남헌
정승일
최영재
박성철
주용찬
김미숙
Original Assignee
천양제지 주식회사
김미숙
최영재
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 천양제지 주식회사, 김미숙, 최영재 filed Critical 천양제지 주식회사
Priority to KR1020080088388A priority Critical patent/KR101039110B1/en
Publication of KR20100029559A publication Critical patent/KR20100029559A/en
Application granted granted Critical
Publication of KR101039110B1 publication Critical patent/KR101039110B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324Foods, ingredients or supplements having a functional effect on health having an effect on the immune system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

본 발명은 닥나무 물 추출물을 함유하는 면역기능 강화용 조성물에 관한 것으로, 구체적으로 본 발명의 닥나무 물 추출물은 생쥐의 비장세포 및 대식 세포의 생장을 촉진하고 NO 생성을 촉진하므로, 본 발명의 닥나무 물 추출물이 면역 활성화 및 증강 효과가 있음을 확인하였으며, 본 발명의 닥나무 물 추출물은 면역기능 강화용 조성물, 면역기능 강화용 건강식품 및 면역기능 저하로 인한 질환의 치료제로 유용하게 이용될 수 있다. The present invention relates to a composition for enhancing immune function containing the water extract of the mulberry, specifically, the mulberry water extract of the present invention promotes the growth of splenocytes and macrophages of mice and promotes the production of NO, the mulberry water of the present invention It was confirmed that the extract has an immune activation and augmentation effect, the water extract of the mulberry of the present invention can be usefully used as a composition for enhancing immune function, health food for enhancing immune function, and a therapeutic agent for diseases caused by reduced immune function.

닥나무, 면역기능 강화. Paper mulberry, enhance immune function.

Description

닥나무 물 추출물을 함유하는 면역기능 강화용 조성물{A water composition comprising Broussonetia kazinoki Sieb. for immunopotentiating}A water composition comprising Broussonetia kazinoki Sieb. for immunopotentiating}

본 발명은 닥나무 물 추출물을 함유하는 면역기능 강화용 조성물, 닥나무 물 추출물을 함유하는 면역기능 강화용 건강식품 및 닥나무 물 추출물을 함유하는 면역기능 저하로 인한 질환용 치료제에 관한 것이다.The present invention relates to a composition for enhancing immune function containing the water extract of mulberry, a health food for enhancing the immune function containing the water extract of mulberry and a therapeutic agent for a disease due to a decrease in immune function containing the water extract of mulberry.

닥나무(Broussonetia kazinoki)는 한자어로는 저목(楮木)이라고 한다. 학명은 Broussonetia kazinoki SIEB., 뽕나무과(Moraceae)의 낙엽활엽관목으로 산언저리 양지쪽에서 볼 수 있는데, 작은 가지에 짧은 털이 밀생하지만 자라면서 없어지고 수피는 회갈색이며, 높이는 약 3 m 정도이다. 잎은 난형 혹은 장타원형으로 가장자리에 날카로운 톱니가 있으며, 벌레가 먹은 것처럼 제각각의 모양으로 찢어져 있다. 꽃은 적자색으로 5-6월에 자웅이주형태로 액출하며, 열매는 핵과로서 구형이며 9월경에 성숙한다. 닥나무는 한방에서 근피를 구피마(構皮麻), 과실을 저실자(楮實子)라 하여 어린가지 및 잎과 함께 여름과 가을철에 채취한다. 잎은 호생하고 난형 또는 난상 타원형이며 긴 점첨두이고 원저 또는 아심장저이며 길이 5-20 cm로서 끝은 날카롭고 간혹 깊이 갈라진 것도 있으며 가장자리에 날카로운 톱니가 있다. 어린 나무에는 2-3개의 결각이 지는 것도 있다. 표면은 거칠며 뒷면은 처음에 털이 있다. 엽병은 길이 1-2cm로서 꼬부라진 털이 있으나 점차 없어진다 (국가생물종지식정보시스템, http://www.nature.go.kr/plant/plantGuide/). 닥나무는 옛날에는 저포라고 불리는 일종의 피륙을 짜는 데 사용되었고, 제지원료로 사용된다. 닥나무를 제지원료로 가공하려면 먼저 수확된 줄기를 1∼2 m 길이로 잘라 밀폐된 솥에 넣고 증기로 찐다. 두 시간 정도 쪄주면 처음 흙냄새가 나다가 단 맛을 띤 향기를 풍기는데, 이 무렵에 꺼내어 껍질을 벗긴다. 이것을 그대로 말린 것을 흑피(黑皮) 또는 조피(粗皮)라고 부르며, 다시 가공하여 백피(白皮)를 얻을 수가 있다. 보통 제지원료로 사용되는 것은 백피이지만, 백피를 제조할 때 긁어낸 검은 껍질도 하급지 원료로 사용된다 (造林技術(金容寬, 英崙社, 1962), 特用林産物栽培와 利用(尹國炳, 英崙社, 1963), 특용수재배학(임경빈, 향문사, 1976), 농산물상품편람(농업협동조합중앙회, 1983), 韓國樹木圖鑑(林業試驗場, 1966), 닥나무재배와 이용(김영련, 산림, 산림조합연합회, 1973)). 약리 작용으로는 거습, 이뇨, 활혈, 류머티즘에 의한 비통, 수종, 타박상, 피부염에 효과가 있다고 알려져 있으며, 화학 성분으로는 Kazinol A, Kazinol B, Kazinol D, Kazinol E, Kazinol F, Kazinol K, Kazinol H, Kazinol Q, Kazinol R, broussonetine W, broussonetine X, broussonetine M1, broussonetine U1, broussonetine J3, broussonetine J2, broussonetine R, broussonetine S, broussonetine T, broussonetine V, broussonetine O, broussonetine P, broussonetine Q, broussonol A, broussonol B, broussonol C, broussonol D, and broussonol E, broussonetinine A, broussonetinine B, 7,4'-dihydroxyflavan, oleanolic acid 등이 함유하고 있다고 알려져 있다.Paper mulberry ( Broussonetia) kazinoki ) is called kanji in Chinese. Scientific name is Broussonetia kazinoki SIEB., a deciduous broad-leaved shrub of the Moraceae family, found on both sides of the mountain, with small hairs growing on the branches, but disappearing as they grow, the bark is grayish brown, about 3 m high. The leaves are ovate or oblong in shape, with sharp teeth on the edges, and are torn in the shape of the insect as eaten. Flowers are reddish purple and discharged in the form of male to female in May-June. Fruits are nucleus spherical and mature in September. The mulberry is collected from the oriental medicine in the summer and autumn together with young branches and leaves. Leaves are regenerated, egg-shaped or egg-shaped oval, long apex, round or subcardiac, 5-20 cm long, with sharp ends, sometimes deeply split, with sharp teeth on the edges. Young trees have 2 to 3 missing lobes. The surface is rough and the back is initially hairy. The petiole is 1-2cm long, with curly hairs but gradually disappears (National Species Information System, http://www.nature.go.kr/plant/plantGuide/). The old mulberry tree was once used to weave a kind of skin called a follicle and used as a support fee. To process the paper mulberry as a support material, first cut the harvested stems into 1 to 2 m lengths and steam them in a closed pot. After two hours of steaming, it smells like earth and gives off a sweet scent. Dried as it is called black skin or black skin (粗 皮), and can be processed again to get white skin (白皮). It is commonly used as a refining fee, but the black skin scraped from the manufacture of white skin is also used as a raw material for the lower grade (造林 技術 (金 容 寬, 英 崙, 1962), 特 用 林 産物 栽培 and 利用 (尹國炳, 英 崙). 1963), Specialty Water Cultivation (Lim Kyung-bin, Hyangmun-sa, 1976), Agricultural Products Handbook (National Association of Agricultural Cooperatives, 1983), 韓國 樹木 圖鑑 (林業 試驗場, 1966) Federation, 1973). Its pharmacological action is known to be effective against roughness, diuresis, blood loss, rheumatism, pain, edema, bruises and dermatitis.The chemical composition of Kazinol A, Kazinol B, Kazinol D, Kazinol E, Kazinol F, Kazinol K, Kazinol H, Kazinol Q, Kazinol R, broussonetine W, broussonetine X, broussonetine M1, broussonetine U1, broussonetine J3, broussonetine J2, broussonetine R, broussonetine S, broussonetine T, broussoneone O, broussonetine O, brousus It is known to contain broussonol B, broussonol C, broussonol D, and broussonol E, broussonetinine A, broussonetinine B, 7,4'-dihydroxyflavan, and oleanolic acid.

면역 활성화를 검증하는 대표적인 방법으로 대식세포 증식 효과 (Friedl R, Moeslinger T, Kopp B, and Spiecke- rmann PG. Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginsena root in Raw 264.7 cells. British Journal of pharma- cology, 2001;134:1663-1670.)와 비장세포의 증식 효과를 선택하였다. NO의 생성 촉진 효과는 대식세포 활성화의 지표로 대식세포에서 생성되는 NO는 침입한 병원치를 없애고 기본적인 숙주 방어체계를 작동시키는 역할을 한다(Farrell AJ, Blake DR. Nitric oxide. Annals of the Rheumatic Dieases. 1996;55:7-20.). 특히 Th 세포의 분화단계 중 ThO 상태에서 Thl과 Th2로 나누어질 때, Thl로의 분화를 돕는 작용을 하는 것으로 알려져 있다. 또한 백혈구의 활성 중 암세포, 기생충 또는 박테리아를 살해하는 세포독성 활성은 NO를 유리시킴으로써 나타나는 것으로 보고되고 있다(Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB Journal. 1992;6: 3051-3064.). 또한 기관지 염증에 NO가 T-cell과 내피세포간의 immunomodulating을 하며 (Bingisser RM, Holt PG Immunomodulating mechanism in the lower respiratory tract; nitric oxide mediated intraction between alveolar macrophage, epithelial cell, and T-cell, SWISS Medical Weekly. 2001;131;171-179.) 강력한 혈소판 응집 억제작용이 있다는 것이 알려져 있다. Representative methods of verifying immune activation are macrophage proliferation effects (Friedl R, Moeslinger T, Kopp B, and Spiecke-rmann PG.Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginsena root in Raw 264.7 cells.British Journal of pharma -cology, 2001; 134: 1663-1670.) and the proliferative effects of splenocytes were selected. NO is a marker of macrophage activation. NO produced in macrophages acts to eliminate invading pathogens and activate basic host defenses (Farrell AJ, Blake DR. Nitric oxide. Annals of the Rheumatic Dieases. 1996; 55: 7-20.). Particularly, when Thl and Th2 are divided in the ThO state during the differentiation of Th cells, it is known to have a function of helping to differentiate into Thl. In addition, cytotoxic activity of killing cancer cells, parasites or bacteria among leukocyte activity has been reported to be released by the release of NO (Nathan C. Nitric oxide as a secretory product of mammalian cells.FASEB Journal. 1992; 6: 3051-3064) .). In addition, NO induced immunomodulating between T-cell and endothelial cells (Bingisser RM, Holt PG Immunomodulating mechanism in the lower respiratory tract; nitric oxide mediated intraction between alveolar macrophage, epithelial cell, and T-cell, SWISS Medical Weekly. 2001; 131; 171-179.) It is known that there is a potent platelet aggregation inhibitory effect.

이에 본 발명자들은 닥나무 물 추출물이 비장 세포 및 대식 세포의 증식을 촉진하며, NO의 생성을 유발하므로 닥나무 물 추출물이 면역 활성화 및 증강 효과가 있음을 확인하므로써 본 발명을 완성하였다.Accordingly, the present inventors completed the present invention by confirming that the water extract of mulberry promotes the proliferation of splenocytes and macrophages, and induces the production of NO.

본 발명의 목적은 닥나무 물 추출물을 유효성분으로 함유하는 면역기능 강화용 조성물, 닥나무 물 추출물을 유효성분으로 함유하는 면역기능 강화용 건강식품 및 이를 유효성분으로 하는 면역기능 저하로 기인한 질환의 치료제를 제공하는 것이다.An object of the present invention is a composition for enhancing immune function containing the water extract of the mulberry as an active ingredient, health foods for enhancing the immune function containing the water extract of mulberry as an active ingredient and a therapeutic agent for diseases caused by a decrease in immune function using the same as an active ingredient To provide.

본 발명은 물로 추출된 닥나무 추출물을 유효성분으로 함유하는 면역기능 강화용 조성물을 제공한다.The present invention provides a composition for enhancing immune function, which contains the extract of the mulberry extract as water as an active ingredient.

또한, 본 발명은 상기 면역기능 강화용 조성물을 유효성분으로 함유하는 면역기능 강화용 건강식품을 제공한다.In addition, the present invention provides a health food for enhancing immune function containing the composition for enhancing immune function as an active ingredient.

또한, 본 발명은 상기 면역기능 강화용 조성물의 제조방법을 제공한다.In addition, the present invention provides a method for producing the composition for enhancing immune function.

또한, 본 발명은 상기 면역기능 강화용 조성물을 유효성분으로 함유하는 면역기능 저하로 기인하는 질환용 치료제를 제공한다.In addition, the present invention provides a therapeutic agent for diseases caused by a decrease in immune function containing the composition for enhancing immune function as an active ingredient.

아울러, 본 발명은 면역기능 저하로 인한 질환의 치료 방법을 제공한다.In addition, the present invention provides a method for the treatment of diseases caused by impaired immune function.

본 발명의 닥나무 물 추출물은 생쥐의 비장세포 및 대식 세포의 생장을 증가시키고, NO의 생성을 증가시키므로 면역기능의 강화에 효과적이므로, 면역기능 강 화용 조성물, 면역기능 강화용 건강식품 및 면역기능 저하로 기인하는 질환용 치료제로 이용하는데 유용하다.Since the water extract of the mulberry of the present invention increases the growth of splenocytes and macrophages in mice, and increases the production of NO, it is effective for strengthening immune function, and thus, composition for enhancing immune function, health food for enhancing immune function, and lowering immune function. It is useful to use as a therapeutic agent for diseases caused by.

이하 본 발명을 설명한다.Hereinafter, the present invention will be described.

본 발명은 물로 추출된 닥나무 추출물을 유효성분으로 함유하는 면역기능 강화용 조성물을 제공한다.The present invention provides a composition for enhancing immune function, which contains the extract of the mulberry extract as water as an active ingredient.

또한, 본 발명은 상기 면역기능 강화용 조성물을 유효성분으로 함유하는 면역기능 강화용 건강식품을 제공한다.In addition, the present invention provides a health food for enhancing immune function containing the composition for enhancing immune function as an active ingredient.

또한, 본 발명은 상기 면역기능 강화용 조성물을 유효성분으로 함유하는 면역기능 저하로 기인하는 질환용 치료제를 제공한다.In addition, the present invention provides a therapeutic agent for diseases caused by a decrease in immune function containing the composition for enhancing immune function as an active ingredient.

아울러, 본 발명은 면역기능 저하로 인한 질환의 치료 방법을 제공한다.In addition, the present invention provides a method for the treatment of diseases caused by impaired immune function.

이하 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명은 물로 추출된 닥나무 추출물을 유효성분으로 함유하는 면역기능 강화용 조성물을 제공한다.The present invention provides a composition for enhancing immune function, which contains the extract of the mulberry extract as water as an active ingredient.

상기 닥나무 줄기를 수득하여 시료 중량의 약 1/5 내지 1 배, 바람직하게는 약 1/3배의 물을 추출용매로 이용하는 것이 바람직하다. 또한 실온에서 약 1 내지 24시간, 바람직하게는 4 내지 15시간 동안, 가장 바람직하게는 2 ~ 3시간 동안 추출하는 것이다. 추출 방법으로는 열수 추출, 냉침 추출, 환류 냉각 추출, 초음파 추출 및 증기 추출 등이 바람직하며, 더욱 바람직하게는 증기 추출 후 동결건조를 수행하므로써 본 발명의 닥나무 물 추출물을 수득할 수 있다. It is preferable to obtain the above-mentioned stems and use about 1/5 to 1 times, preferably about 1/3 times, water as the extraction solvent. The extraction is also performed at room temperature for about 1 to 24 hours, preferably 4 to 15 hours, most preferably 2 to 3 hours. The extraction method is preferably hot water extraction, cold extraction, reflux cooling extraction, ultrasonic extraction and steam extraction, more preferably by performing the lyophilization after steam extraction can be obtained the water extract of the mulberry tree of the present invention.

본 발명자들은 상기와 같이 추출된 닥나무 물 추출물이 생쥐의 비장 세포, 대식 세포의 생장에 미치는 영향을 조사하였다. 그 결과, 비장세포의 증식을 유발하며(도 1 및 표 1 참조), 대식 세포에서도 탁월한 증식 효과를 보이며, 양성 대조군에 비해서도 우월하게 효율적임을 확인하였다(도 2 및 표 2 참조). The present inventors investigated the effect of the water extract of the mulberry extract as described above on the growth of spleen cells, macrophages of mice. As a result, it induces the proliferation of splenocytes (see Fig. 1 and Table 1), showed an excellent proliferation effect also in macrophages, it was confirmed to be superior to the positive control (see Fig. 2 and Table 2).

이후 본 발명자들은 닥나무 물 추출물이 NO 생성에 미치는 영향을 조사하였다. 그 결과, NO 생성 또한 효과적으로 유발하여 면역 증강에 효과적임을 확인하였다(도 3 및 표 3 참조).The inventors then investigated the effect of the water extract of the mulberry on NO production. As a result, it was confirmed that the production of NO also effectively effective in boosting immunity (see FIG. 3 and Table 3).

그러므로 본 발명의 닥나무 물 추출물은 면역기능 강화용 조성물에 효율적으로 이용될 수 있다. Therefore, the water extract of the mulberry of the present invention can be efficiently used in the composition for enhancing immune function.

본 발명의 면역기능 강화용 조성물은 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽, 에어로졸 등의 경구형 제형, 외용제, 좌제 및 멸균 주사용액의 형태로 제형화하여 사용될 수 있다. 목초액을 함유하는 조성물에 포함될 수 있는 담체, 부형제 및 희석제로는 락토즈, 덱스트로즈, 수크로스, 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로즈, 메틸 셀룰로즈, 미정질 셀룰로스, 폴리비닐 피롤리돈, 물, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유를 들 수 있다. 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다.The composition for enhancing immune function of the present invention may be used in the form of powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols, oral formulations, external preparations, suppositories, and sterile injectable solutions. Carriers, excipients, and diluents that may be included in compositions containing wood vinegar include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium silicate , Cellulose, methyl cellulose, microcrystalline cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil. When formulated, diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrating agents, and surfactants are usually used.

경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 상기 생약 추출액에 적어도 하나 이상의 부형제, 예를 들면, 전분, 칼슘카보네이트(calcium carbonate), 수크로오스(sucrose) 또는 락토오스(lactose), 젤라틴 등을 섞어 조제된다. 또한 단순한 부형제 이외에 마그네슘 스테아레이트, 탈크 같은 윤활제들도 사용된다. 경구를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다.Solid preparations for oral administration include tablets, pills, powders, granules, capsules, and the like, and the solid preparations may include at least one excipient such as starch, calcium carbonate, sucrose ( It is prepared by mixing sucrose or lactose and gelatin. In addition to simple excipients, lubricants such as magnesium stearate and talc are also used. Oral liquid preparations include suspensions, solvents, emulsions, and syrups, and may include various excipients, such as wetting agents, sweeteners, fragrances, and preservatives, in addition to commonly used simple diluents such as water and liquid paraffin. .

비경구 투여를 위한 제제에는 멸균된 수용액, 액제, 비수성용제, 현탁제, 유제, 동결건조 제제, 좌제, 주사제제가 포함된다. 비수성용제, 현탁제로는 프로필렌글리콜(propylene glycol), 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈(tween) 61, 카카오지, 라우린지, 글리세로제라틴 등이 사용될 수 있다.Formulations for parenteral administration include sterile aqueous solutions, solutions, non-aqueous solutions, suspensions, emulsions, lyophilized preparations, suppositories, injections. As the non-aqueous solvent and suspending agent, propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate and the like can be used. As the base of the suppository, witepsol, macrogol, tween 61, cacao butter, laurin butter, glycerogelatin and the like can be used.

또한, 본 발명은 상기 면역기능 강화용 조성물을 유효성분으로 함유하는 면역기능 강화용 건강식품을 제공한다.In addition, the present invention provides a health food for enhancing immune function containing the composition for enhancing immune function as an active ingredient.

닥나무 물 추출물을 첨가할 수 있는 식품으로는, 예를 들어, 각종 식품류, 유제품, 음료, 껌, 차, 비타민 단일제, 건강보조 식품류 등이 있고, 분말, 과립, 정제, 캡슐 또는 음료인 형태로 사용할 수 있다.Examples of foods to which the water extract may be added include, for example, various foods, dairy products, beverages, gums, teas, vitamin monosaccharides, dietary supplements, etc. Can be.

또한, 면역기능 강화를 목적으로 식품 또는 음료에 첨가될 수 있다. 이 때, 식품 또는 음료 중의 상기 추출물의 양은 전체 식품 중량의 0.01 내지 15 중량%로 가할 수 있으며, 건강 음료 조성물은 100 ㎖를 기준으로 0.02 내지 5 g, 바람직하게는 0.3 내지 1 g의 비율로 가할 수 있다. It may also be added to foods or beverages for the purpose of enhancing immune function. At this time, the amount of the extract in the food or beverage can be added in 0.01 to 15% by weight of the total food weight, the health beverage composition is added in a ratio of 0.02 to 5 g, preferably 0.3 to 1 g based on 100 ml Can be.

본 발명의 건강 기능성 음료 조성물은 지시된 비율로 필수 성분으로서 상기 닥나무 물 추출물을 함유하는 외에는 다른 성분에는 특별한 제한이 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 수크로오스 등; 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리트리톨 등의 당알코올이다. 상술한 것 이외의 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 ㎖당 일반적으로 약 1 내지 20 g, 바람직하게는 약 5 내지 12 g이다.The health functional beverage composition of the present invention is not particularly limited to other ingredients except for containing the above-mentioned mulberry water extract as an essential ingredient in the indicated ratio, and may contain various flavors or natural carbohydrates as additional ingredients, such as ordinary drinks. have. Examples of the above-mentioned natural carbohydrates include monosaccharides such as glucose, fructose and the like; Disaccharides such as maltose, sucrose and the like; And conventional sugars such as polysaccharides such as dextrin, cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As flavoring agents other than those mentioned above, natural flavoring agents (tauumatin, stevia extract (for example, rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used. The proportion of said natural carbohydrates is generally about 1-20 g, preferably about 5-12 g per 100 ml of the composition of the present invention.

상기 외에 본 발명의 닥나무 물 추출물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜 릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 그밖에 본 발명의 닥나무 물 추출물은 천연 과일 주스 및 과일 주스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 그렇게 중요하진 않지만 본 발명의 닥나무 100 중량부 당 0.1 내지 약 20 중량부의 범위에서 선택되는 것이 일반적이다.In addition to the above, the mulberry water extract of the present invention is a variety of nutrients, vitamins, minerals (electrolytes), synthetic and natural flavors, such as flavoring agents, coloring and neutralizing agents (cheese, chocolate, etc.), pectic acid and salts thereof, Alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, and the like. In addition, the mulberry water extract of the present invention may contain a flesh for preparing natural fruit juice and fruit juice beverage and vegetable beverage. These components can be used independently or in combination. The proportion of such additives is not so critical but is generally selected in the range of 0.1 to about 20 parts by weight per 100 parts by weight of the mulberry of the present invention.

또한, 본 발명은 상기 면역기능 강화용 조성물을 유효성분으로 함유하는 면역기능 저하로 인한 질환용 치료제를 제공한다.In addition, the present invention provides a therapeutic agent for diseases caused by a decrease in immune function containing the composition for enhancing immune function as an active ingredient.

상기 면역기능 저하로 기인되는 질환으로는 감기 등의 감염성 질환 및 염증성 질환, 아토피 등의 알러지 질환, 만성피로, 암 등으로 이루어진 군으로부터 선택되는 어느 하나인 것이 바람직하나 이에 한정되는 것은 아니며, 당업자에 알려진 면역기능 저하로 기인되는 질환은 모두 본 발명에 포함된다. 본 발명의 닥나무 물 추출물의 바람직한 투여량은 환자의 상태 및 체중, 질병의 정도, 약물형태, 투여경로 및 기간에 따라 다르지만, 당업자에 의해 적절하게 선택될 수 있다. 그러나 바람직한 효과를 위해서, 본 발명의 닥나무 물 추출물은 1일 0.0001 내지 500 ㎎/㎏으로, 바람직하게는 0.001 내지 500 ㎎/㎏으로 투여하는 것이 좋다. 투여는 하루에 한번 투여할 수도 있고, 수회 나누어 투여할 수도 있다. 상기 투여량은 어떠한 면으로든 본 발명의 범위를 한정하는 것은 아니다.The disease caused by the reduced immune function is preferably any one selected from the group consisting of infectious diseases such as cold and inflammatory diseases, allergic diseases such as atopic dermatitis, chronic fatigue, cancer and the like, but is not limited thereto. All diseases resulting from a known decrease in immune function are included in the present invention. Preferred dosages of the water extract of Methanol of the present invention vary depending on the condition and weight of the patient, the extent of the disease, the form of the drug, the route of administration and the duration, and may be appropriately selected by those skilled in the art. However, for the desired effect, the water extract of the mulberry of the present invention is preferably administered at 0.0001 to 500 mg / kg, preferably at 0.001 to 500 mg / kg. Administration may be administered once a day or may be divided several times. The dosage does not limit the scope of the invention in any aspect.

아울러, 본 발명은 면역기능 저하로 인한 질환의 치료 방법을 제공한다.In addition, the present invention provides a method for the treatment of diseases caused by impaired immune function.

상기 치료 방법은 하기의 단계를 포함한다: 대상에 본 발명의 닥나무 물 추출물을 유효성분으로 투여하는 단계.The method of treatment comprises the following steps: administering the water extract of the mulberry of the present invention to the subject as an active ingredient.

상기 방법에 있어서, 본 발명의 닥나무 물 추출물은 다양한 경로로 투여될 수 있다. 투여의 모든 방식은 예상될 수 있는데, 예를 들면, 경구, 직장 또는 정맥, 근육, 피하, 자궁내 경막 또는 뇌혈관내(intracerebroventricular) 주사에 의해 투여될 수 있다. In the above method, the mulberry water extract of the present invention may be administered by various routes. All modes of administration may be expected, for example, by oral, rectal or intravenous, intramuscular, subcutaneous, intra-uterine or intracerebroventricular injections.

이하, 본 발명을 실시예, 실험예 및 제제예에 의하여 상세히 설명한다.Hereinafter, the present invention will be described in detail by Examples, Experimental Examples and Formulation Examples.

단, 하기 실시예, 실험예 및 제제예는 본 발명을 구체적으로 예시하는 것이며, 본 발명의 내용이 실시예, 실험예 및 제제예에 의해 한정되는 것은 아니다.However, the following Examples, Experimental Examples, and Formulation Examples specifically illustrate the present invention, and the content of the present invention is not limited to Examples, Experimental Examples, and Formulation Examples.

<실시예 1> 닥나무(Example 1 Broussonetia kazinokiBroussonetia kazinoki Sieb.) 물 추출물 제조 Sieb.) Water Extract Manufacturer

닥나무 증기 추출액은 (주)천양제지에서 한지 제조 공정 중 생산되는 것을 수집하여 전주생물소재연구소에서 동결건조한 것을 사용하였다. 베어낸 닥나무 줄기를 1 - 1.5 m 길이를 잘라서 가지런히 한 다음 약 15 - 20 ㎏ 정도의 작은 단으로 묶어 직경 2 m, 깊이 1 m 정도의 철제 원통에 물을 1/3 정도 채운 후 닥나무를 세로로 세워 약 450-600 ㎏ 넣고 둘레를 움직이지 않게 단단히 고정시켰다. 외부를 비닐 씌워 증기가 빠져나가지 않도록 하고 증기의 공급으로 2-3시간 가열하였다. 충분히 쪄진 닥나무를 제거하고 원통 아래의 닥나무 추출액을 회수하여 감압농축시킨 후 동결건조하여 실험에 사용하였다. 건조된 닥나무 물 추출물의 수율은 1.3% 였다. The mulberry steam extract was collected from Cheonyang Paper Co., Ltd. during the manufacturing process of Hanji and used by lyophilization at Jeonju Biomaterials Research Institute. Cut 1 ~ 1.5 m long stems, trim them, and tie them together in small steps of about 15-20 kg. Fill a 2 m diameter, 1 m deep steel cylinder with 1/3 of water, and then cut them up. About 450-600 kg was put up and fixed firmly to move the circumference. The outside was covered with vinyl to prevent steam from escaping and heated for 2-3 hours by steam supply. Sufficiently steamed mulberry was removed, and the extract of the mulberry under the cylinder was recovered, concentrated under reduced pressure, and lyophilized to be used for the experiment. The yield of dried mulberry water extract was 1.3%.

<실험예 1> 생쥐 비장 세포의 세포증식 효과 조사Experimental Example 1 Investigation of Cell Proliferation Effect of Mouse Spleen Cells

7주령의 수컷 C57BL/6 마우스(대한바이오링크, 충북 음성)를 경추탈골 후 비장을 적출하였다. 적출한 비장을 HBSS(Hank's Balanced Salts Modified. Gbico BRL.)로 세척하고 세포 분리 후 원심분리하여 RBC 세포용해 버퍼(lysing buffer, Sigma)로 적혈구를 제거한 후 10% FBS(fetal bovine serum, Gibco BRL.)와 페니실린(penicillin, Gibco BRL.) 및 스트렙토마이신(streptomycin, Gibco BRL.)을 함유하는 RPMI 1640(Hyclone) 배지에 부유시켜 5% CO2, 37℃에서 배양하였다. 상기 실시예 1에서 제조된 닥나무 물 추출물이 비장 세포 증식에 미치는 효과를 검색하기 위하여 96-웰 플레이트(well plate)에 분리 배양한 비장 세포를 5×105 cells/well로 분주하고 닥나무 물 추출물을 1~100 μg/ml 농도로 PBS에 용해하여 첨가하였다. 세포증식 효과에 대한 비교물질로 ConA(Concanavalin A, Sigma Co., U.S.A)와 LPS(lipopolysaccharide, Sigma Co., U.S.A) 2 μg/ml로 각각 사용하였다. 48시간 배양 후 테트라졸리움 염인 CCK-8 kit(Cell Counting Kit-8, Dojindo Laboratories, Tokyo, Japan) 용액을 첨가하여 4시간 더 배양한 다음 ELISA 리더 기(Ceres UV 900C, Bio-tech instrument, U.S.A.)를 이용하여 450 nm에서 흡광도를 측정하였다. 대조군 웰(Control well)의 흡광도에 대한 약물첨가 well의 흡광도의 비를 %로 계산하였고, 여러 웰(well)의 평균값을 사용하였다. 계산식은 다음과 같다.Seven-week-old male C57BL / 6 mice (Korean Biolink, Chungbuk Negative) were extracted after the cervical spine bone. The extracted spleens were washed with HBSS (Hank's Balanced Salts Modified.Gbico BRL.), Centrifuged and separated to remove red blood cells with RBC lysing buffer (Sigma), followed by 10% FBS (fetal bovine serum, Gibco BRL. ) And penicillin (penicillin, Gibco BRL.) And streptomycin (streptomycin, Gibco BRL.) And suspended in RPMI 1640 (Hyclone) medium containing and cultured at 5% CO 2 , 37 ℃. In order to detect the effect of the water extract of the mulberry prepared in Example 1 on the spleen cell proliferation, the splenocytes separated and cultured in a 96-well plate were divided into 5 × 10 5 cells / well and the mulberry water extract was It was added by dissolving in PBS at a concentration of 1-100 μg / ml. As a comparison material for the cell proliferation effect, ConA (Concanavalin A, Sigma Co., USA) and LPS (lipopolysaccharide, Sigma Co., USA) were used as 2 μg / ml, respectively. After 48 hours of incubation, the solution was added with a solution of tetrazolium salt CCK-8 kit (Cell Counting Kit-8, Dojindo Laboratories, Tokyo, Japan) for 4 hours, followed by ELISA reader (Ceres UV 900C, Bio-tech instrument, USA). Absorbance was measured at 450 nm using. The ratio of the absorbance of drug addition wells to the absorbance of control wells was calculated in% and the average value of several wells was used. The calculation is as follows.

Figure 112008063684863-pat00001
Figure 112008063684863-pat00001

그 결과, 닥나무 물 추출물을 쥐에서 분리한 비장세포에 1~100 μg/ml로 처리하였을 때 비장세포의 증식효과가 농도의존적으로 증가되었다(도 1). 이는 양성대조군으로 사용한 LPS와 ConA를 2 μg/ml 처리한 경우 대조군의 203.4 ± 5.1, 224.9 ± 17.7%로 증가한 것으로 나타났으므로 닥나무 물 추출물은 비장세포의 증식을 유발하여 면역 증강에 효과적임을 확인하였다. As a result, the proliferation effect of the splenocytes was increased concentration-dependently when treated with 1 ~ 100 μg / ml to the spleen cells isolated from the rat water extract (March) (Fig. 1). This resulted in an increase of 203.4 ± 5.1 and 224.9 ± 17.7% of the control group when 2 μg / ml of LPS and ConA were used as the positive control group. .

닥나무 물 추출물의 생쥐 Mice of Methanol Water Extract 비장세포의Splenocyte 세포증식 효과 조사 Investigation of cell proliferation effect 세포증식률(%)Cell growth rate (%) 양성대조군Positive control group LPS 2㎍/㎖LPS 2 µg / ml 203.47±5.06203.47 ± 5.06 ConA 2 ㎍/㎖2 μg / ml ConA 224.94±17.69224.94 ± 17.69 실시예 1-1의 닥나무 물 추출물Paper mulberry water extract of Example 1-1 1 ㎍/㎖1 μg / ml 133.18±5.35133.18 ± 5.35 5 ㎍/㎖5 μg / ml 177.68±6.17177.68 ± 6.17 10 ㎍/㎖10 μg / ml 185.66±2.56185.66 ± 2.56 50 ㎍/㎖50 μg / ml 210.01±2.66210.01 ± 2.66 100 ㎍/㎖100 μg / ml 202.41±3.66202.41 ± 3.66

<< 실험예Experimental Example 2> 생쥐 대식 세포주의 세포 증식 및  2> cell proliferation of mouse macrophage lines and NONO (( nitricnitric oxideoxide ) 생성 효과 조사Investigate the creation effect

<2-1> 생쥐 대식 세포주의 세포 증식 효과 조사<2-1> Investigation of Cell Proliferation in Mouse Macrophage Cell Line

쥐 대식 세포주(Murin macrophage cell line)인 Raw 264.7 세포주를 96-웰 플레이트에 5 × 103 cells/well로 분주하고 물 추출물을 1~100 μg/ml 농도로 처리하였다. 비교물질로는 ConA(Sigma Co., U.S.A)와 LPS(Sigma Co., U.S.A) 2 μg/ml로 각각 사용하였다. 48시간 배양 후 테트라졸리움 염인 CCK-8 kit(Cell Counting Kit-8, Dojindo Laboratories, Tokyo, Japan) 용액을 첨가하여 4시간 더 배양한 다음 ELISA 리더기(Ceres UV 900C, Bio-tech instrument, U.S.A.)를 이용하여 450 nm에서 흡광도를 측정하였다. 대조군 웰(Control well)의 흡광도에 대한 약물첨가 well의 흡광도의 비를 %로 계산하였고, 여러 웰(well)의 평균값을 사용하였다. 계산식은 다음과 같다.Raw 264.7 cell line, a Murin macrophage cell line, was dispensed in 96-well plates at 5 × 10 3 cells / well and treated with water extract at a concentration of 1-100 μg / ml. As a comparison material, ConA (Sigma Co., USA) and LPS (Sigma Co., USA) were used at 2 μg / ml, respectively. After 48 hours of incubation, add tetrazolium salt CCK-8 kit (Cell Counting Kit-8, Dojindo Laboratories, Tokyo, Japan) solution and incubate for 4 hours more, then use ELISA reader (Ceres UV 900C, Bio-tech instrument, USA). Absorbance at 450 nm was measured. The ratio of the absorbance of drug addition wells to the absorbance of control wells was calculated in% and the average value of several wells was used. The calculation is as follows.

Figure 112008063684863-pat00002
Figure 112008063684863-pat00002

그 결과, 닥나무 물 추출물을 생쥐 대식세포주인 RAW 264.7 세포주에 1~100 μg/ml로 처리하였을 때 세포증식효과가 양성대조군으로 사용한 LPS보다 높게 나타났으므로 닥나무 물 추출물은 대식세포의 증식을 유발하여 면역 증강에 효과적임을 확인하였다(도 2).As a result, when the mulberry water extract was treated with 1 ~ 100 μg / ml in the RAW 264.7 cell line, which is a mouse macrophage, the cell proliferation effect was higher than that of the LPS used as the positive control group. It was confirmed that it is effective for boosting immunity (FIG. 2).

닥나무 물 추출물의 생쥐 대식세포의 세포증식 효과 조사Investigation of the Cell Proliferation Effect of Macrophage in Mice 세포증식률(%)Cell growth rate (%) 양성대조군Positive control group LPS 2㎍/㎖LPS 2 µg / ml 123.14±2.09123.14 ± 2.09 ConA 2㎍/㎖ConA 2µg / ml 63.80±0.8863.80 ± 0.88 실시예 1-1의 닥나무 물 추출물Paper mulberry water extract of Example 1-1 1 ㎍/㎖1 μg / ml 152.06±5.24152.06 ± 5.24 5 ㎍/㎖5 μg / ml 163.88±2.23163.88 ± 2.23 10 ㎍/㎖10 μg / ml 163.56±1.49163.56 ± 1.49 50 ㎍/㎖50 μg / ml 155.80±1.32155.80 ± 1.32 100 ㎍/㎖100 μg / ml 147.61±1.51147.61 ± 1.51

<2-2> 생쥐 대식 세포주의 NO 생성 효과 조사<2-2> NO Production Effect of Mouse Macrophage Cell Line

Raw 264.7 세포를 2.5×105 cells/well로 48-웰 플레이트에 분주하여 CO2 배양기 내에서 24시간 배양한 후 양성 대조군으로 LPS를 농도별로 처리하였다. 약물 처리군에는 물 추출물을 1~100 μg/ml 로 처리하고 18시간 배양 후 상층액을 분리하고 NO 생성량을 측정하였다. NO 생성량은 Griess reagent(Promega, U.S.A)를 이용하여 반응시켰으며 535 nm에서 흡광도를 측정하였다.Raw 264.7 cells were aliquoted into 2.5 × 10 5 cells / well in 48-well plates, incubated in CO 2 incubator for 24 hours, and treated with LPS by concentration as a positive control. In the drug treatment group, water extract was treated with 1-100 μg / ml, the supernatant was separated after 18 hours of incubation, and NO production was measured. NO production was reacted using Griess reagent (Promega, USA) and the absorbance was measured at 535 nm.

그 결과, 닥나무 물 추출물을 생쥐 대식세포주인 RAW 264.7 세포주에 1~100 μg/ml로 처리하였을 때 NO 생성 촉진효과가 우수한 것으로 나타났다. 닥나무 물 추출물은 대식세포의 증식을 유발할 뿐만 아니라 대식세포에서 NO의 생성도 촉진하여 면역 증강에 효과적임을 확인하였다(도 3).As a result, when the water extract of the mulberry tree was treated with 1 ~ 100 μg / ml in the RAW 264.7 cell line, which is a mouse macrophage, the NO production promoting effect was excellent. It was confirmed that the water extract of mulberry not only induces the proliferation of macrophages but also promotes the production of NO in the macrophages and is effective in enhancing immunity (FIG. 3).

닥나무 물 추출물의 생쥐 Mice of Methanol Water Extract 비장세포Splenocytes 내의  undergarment NONO 생성 효과 조사 Generating Effect Survey NO 생성량 (μM)NO production amount (μM) 대조군 (시료무처리군)Control group (No sample group) -- 0.80±0.100.80 ± 0.10 양성대조군Positive control group LPS 0.4 ㎍/㎖LPS 0.4 μg / ml 38.93±0.5338.93 ± 0.53 LPS 4 ㎍/㎖LPS 4 μg / ml 42.92±1.7142.92 ± 1.71 실시예 1-1의 닥나무 물 추출물Paper mulberry water extract of Example 1-1 1 ㎍/㎖1 μg / ml 0.60±0.050.60 ± 0.05 10 ㎍/㎖10 μg / ml 0.95±0.050.95 ± 0.05 100 ㎍/㎖100 μg / ml 24.43±0.8524.43 ± 0.85

상기 결과를 통해 본 발명의 닥나무 물 추출물이 생쥐 비장세포의 세포증식, 대식세포의 증식, 대식세포의 NO 생성 촉진에 대해 우수한 효과를 나타냈으므로 본 발명의 닥나무 물 추출물은 면역 활성화 및 면역 기능 강화에 사용될 수 있음을 제시한다. According to the above results, the water extract of the present invention showed the excellent effect on the cell proliferation of the mouse splenocytes, the proliferation of macrophages, the promotion of NO production of macrophages, the water extract of the present invention is the immune activation and immune function enhancement It can be used for.

하기에 본 발명의 조성물을 위한 제제예를 예시한다.Examples of formulations for the composition of the present invention are illustrated below.

<제제예 1> 약학적 제제의 제조Preparation Example 1 Preparation of Pharmaceutical Formulation

<1-1> 산제의 제조 <1-1> Preparation of powders

본 발명의 닥나무 물 추출물 2 g2 g of young water extract of the present invention

유당 1 g1 g lactose

상기의 성분을 혼합한 후, 기밀포에 충진하여 산제를 제조하였다.After mixing the above components, the airtight cloth was filled to prepare a powder.

<1-2> 정제의 제조 <1-2> Preparation of Tablet

본 발명에 따른 닥나무 물 추출물 100 ㎎100 mg of water extract according to the present invention

옥수수전분 100 ㎎Corn starch 100 mg

유 당 100 ㎎Lactose 100 mg

스테아린산 마그네슘 2 ㎎2 mg magnesium stearate

상기의 성분을 혼합한 후, 통상의 정제의 제조방법에 따라서 타정하여 정제를 제조하였다.After mixing the above components, tablets were prepared by tableting according to a conventional method for producing tablets.

<1-3> 캡슐제의 제조 <1-3> Preparation of Capsule

본 발명의 닥나무 물 추출물 100 ㎎100mg of Methanol Water Extract of the Invention

옥수수전분 100 ㎎Corn starch 100 mg

유 당 100 ㎎Lactose 100 mg

스테아린산 마그네슘 2 ㎎2 mg magnesium stearate

상기의 성분을 혼합한 후, 통상의 캡슐제의 제조방법에 따라서 젤라틴 캡슐에 충전하여 캡슐제를 제조하였다.After mixing the above components, the capsule was prepared by filling in gelatin capsules according to the conventional method for producing a capsule.

<1-4> 주사액제의 제조 <1-4> Preparation of Injection Solution

본 발명에 따른 닥나무 물 추출물 10 ㎍/㎖10 ㎍ / ml of the water extract of the mulberry according to the present invention

묽은 염산 BP pH 3.5로 될 때까지Dilute hydrochloric acid BP until pH 3.5

주사용 염화나트륨 BP 최대 1 ㎖Injectable sodium chloride BP up to 1 ml

적당한 용적의 주사용 염화나트륨 BP 중에 본 발명에 따른 목이버섯 균사체 분말을 용해시키고, 생성된 용액의 pH를 묽은 염산 BP를 사용하여 pH 3.5로 조절하고, 주사용 염화나트륨 BP를 사용하여 용적을 조절하고 충분히 혼합하였다. 용액을 투명 유리로 된 5 ㎖ 타입 I 앰플 중에 충전시키고, 유리를 용해시킴으로써 공기의 상부 격자하에 봉입시키고, 120 ℃에서 15 분 이상 오토클래이브시켜 살균하여 주사액제를 제조하였다.Dissolve the wood mushroom mycelium powder according to the present invention in an appropriate volume of sodium chloride BP for injection, adjust the pH of the resulting solution to pH 3.5 with dilute hydrochloric acid BP, and adjust the volume with sodium chloride BP for injection and sufficiently Mixed. The solution was filled into a 5 ml Type I ampoule made of clear glass, encapsulated under an upper grid of air by dissolving the glass, and sterilized by autoclaving at 120 ° C. for at least 15 minutes to prepare an injection solution.

<< 제제예Formulation example 2> 식품의 제조 2> Manufacture of food

본 발명에 따른 본 발명의 닥나무 물 추출물을 포함하는 식품들을 다음과 같이 제조하였다.Foods comprising the water extract of the mulberry of the present invention according to the present invention were prepared as follows.

<2-1> 밀가루 식품의 제조 <2-1> Preparation of Flour Food

본 발명의 닥나무 물 추출물 0.1 ~ 10.0 중량부를 밀가루에 첨가하고, 이 혼합물을 이용하여 통상의 방법으로 빵, 케이크, 쿠키, 크래커 및 면류를 제조하여 건강 증진용 식품을 제조하였다.0.1 ~ 10.0 parts by weight of the water extract of the mulberry of the present invention was added to the flour, and using the mixture, bread, cake, cookies, crackers and noodles were prepared in a conventional manner to prepare foods for health promotion.

<2-2> 스프 및 육즙(gravies)의 제조 <2-2> Preparation of Soups and Gravys

본 발명의 닥나무 물 추출물 0.1 ~ 1.0 중량부를 스프 및 육즙에 첨가하여 통상의 방법으로 건강 증진용 육가공 제품, 면류의 수프 및 육즙을 제조하였다.0.1-1.0 parts by weight of the water extract of Methanol of the present invention was added to soups and gravy to prepare meat products for health promotion, soup of noodles and gravy in a conventional manner.

<2-3> 그라운드 비프(ground beef)의 제조 <2-3> Preparation of Ground Beef

본 발명의 닥나무 물 추출물 10 중량부를 그라운드 비프에 첨가하여 통상의 방법으로 건강 증진용 그라운드 비프를 제조하였다.10 parts by weight of the water extract of the mulberry of the present invention was added to the ground beef to prepare a ground beef for health promotion in a conventional manner.

<2-4> 유제품( dairy products )의 제조 <2-4> dairy products (dairy products )

본 발명의 닥나무 물 추출물 0.1 ~ 1.0 중량부를 우유에 첨가하고, 상기 우유를 이용하여 통상의 방법으로 버터 및 아이스크림과 같은 다양한 유제품을 제조하였다.0.1-1.0 parts by weight of the water extract of Methanol of the present invention was added to milk, and various dairy products such as butter and ice cream were prepared in a conventional manner using the milk.

<2-5> 선식의 제조 <2-5> Preparation of Wire

현미, 보리, 찹쌀, 율무를 공지의 방법으로 알파화시켜 건조시킨 것을 배전한 후 분쇄기로 입도 60 메쉬의 분말로 제조하였다.Brown rice, barley, glutinous rice, and yulmu were dried by a known method and dried, and the mixture was granulated to a powder having a particle size of 60 mesh.

검정콩, 검정깨, 들깨도 공지의 방법으로 쪄서 건조시킨 것을 배전한 후 분쇄기로 입도 60 메쉬의 분말로 제조하였다.Black soybeans, black sesame seeds, and perilla seeds were steamed and dried by a conventional method, and then they were prepared into powder having a particle size of 60 mesh by a pulverizer.

본 발명의 닥나무 물 추출물을 진공 농축기에서 감압, 농축하고, 분무, 열풍건조기로 건조하여 얻은 건조물을 분쇄기로 입도 60 메쉬로 분쇄하여 건조분말을 얻었다.The water extract of the present invention was concentrated under reduced pressure and concentrated in a vacuum concentrator, and dried by spraying and drying with a hot air dryer to grind the dried product to a particle size of 60 mesh using a grinder to obtain a dry powder.

상기에서 제조한 곡물류, 종실류 및 본 발명에 따른 목이버섯 균사체 분말을 다음의 비율로 배합하여 통상의 방법으로 제조하였다.The grains, seeds and the mycelium mycelium mycelium powder according to the present invention were prepared in the following ratio to prepare a conventional method.

곡물류(현미 30 중량부, 율무 15 중량부, 보리 20 중량부),Cereals (30 parts by weight brown rice, 15 parts by weight brittle, 20 parts by weight of barley),

종실류(들깨 7 중량부, 검정콩 8 중량부, 검정깨 7 중량부),Seeds (7 parts by weight of perilla, 8 parts by weight of black beans, 7 parts by weight of black sesame seeds)

본 발명의 닥나무 물 추출물(1 중량부),Methanol water extract of the present invention (1 part by weight),

영지(0.5 중량부),(0.5 part by weight),

지황(0.5 중량부)Foxglove (0.5 part by weight)

<< 제제예Formulation example 3> 음료의 제조 3> Manufacturing of beverage

본 발명의 닥나무 물 추출물을 포함하는 음료를 다음과 같이 제조하였다.Drinks containing the water extract of the mulberry of the present invention was prepared as follows.

<3-1> 건강음료의 제조 <3-1> Preparation of Health Beverage

액상과당(0.5%), 올리고당(2%), 설탕(2%), 식염(0.5%), 물(75%)과 같은 부재료와 본 발명에 따른 닥나무 물 추출물을 균질하게 배합하여 순간 살균을 한 후, 이를 유리병, 패트병 등 소포장 용기에 포장하여 건강음료를 제조하였다.Instant sterilization was carried out by homogeneously mixing the ingredients such as liquid fructose (0.5%), oligosaccharides (2%), sugar (2%), salt (0.5%), water (75%) and the water extract of the mulberry according to the present invention. Then, it was packaged in a small packaging container such as glass bottles, plastic bottles to prepare a healthy beverage.

<3-2> 야채쥬스의 제조 <3-2> Preparation of Vegetable Juice

본 발명의 닥나무 물 추출물 0.5 g을 토마토 또는 당근 등의 야채의 쥬스 1,000 ㎖에 가하여 통상의 방법으로 건강 증진용 야채쥬스를 제조하였다.0.5 g of the water extract of the present invention was added to 1,000 ml of vegetable juices such as tomatoes or carrots to prepare vegetable juice for health promotion in a conventional manner.

<3-3> 과일쥬스의 제조 <3-3> Preparation of Fruit Juice

본 발명의 닥나무 물 추출물 0.1 g을 사과 또는 포도 등의 과일의 쥬스 1,000 ㎖에 가하여 통상의 방법으로 건강 증진용 과일쥬스를 제조하였다.0.1 g of the water extract of the mulberry of the present invention was added to 1,000 ml of fruit juices such as apples or grapes to prepare fruit juice for health promotion in a conventional manner.

도 1은 생쥐 비장세포에서 본 발명의 닥나무 물 추출물 처리에 따른 비장세포의 증식 효과를 나타내는 그래프이다.1 is a graph showing the proliferative effect of splenocytes according to the treatment of the water extract of the present invention in the mouse splenocytes.

도 2는 생쥐 대식세포주에서 본 발명의 닥나무 물 추출물 처리에 따른 대식세포주의 증식 효과를 나타내는 그래프이다.Figure 2 is a graph showing the proliferation effect of the macrophage cell line according to the treatment of the water extract of the present invention in the mouse macrophage line.

도 3은 생쥐 대식세포주에서 본 발명의 닥나무 물 추출물 처리에 따른 NO 생성 유발 효과를 나타내는 그래프이다. Figure 3 is a graph showing the NO production inducing effect according to the treatment of the water extract of the present invention in the mouse macrophage line.

Claims (5)

삭제delete 삭제delete 물로 추출된 닥나무 추출물을 유효성분으로 함유하는 면역기능 강화용 건강식품.Health food for strengthening immune function, containing medicinal extracts of water extracts from water. 삭제delete 삭제delete
KR1020080088388A 2008-09-08 2008-09-08 A water composition comprising Broussonetia kazinoki Sieb. for immunopotentiating KR101039110B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020080088388A KR101039110B1 (en) 2008-09-08 2008-09-08 A water composition comprising Broussonetia kazinoki Sieb. for immunopotentiating

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080088388A KR101039110B1 (en) 2008-09-08 2008-09-08 A water composition comprising Broussonetia kazinoki Sieb. for immunopotentiating

Publications (2)

Publication Number Publication Date
KR20100029559A KR20100029559A (en) 2010-03-17
KR101039110B1 true KR101039110B1 (en) 2011-06-15

Family

ID=42179765

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020080088388A KR101039110B1 (en) 2008-09-08 2008-09-08 A water composition comprising Broussonetia kazinoki Sieb. for immunopotentiating

Country Status (1)

Country Link
KR (1) KR101039110B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220029828A (en) 2020-08-28 2022-03-10 엠테라파마 주식회사 A composition for improving insulin sensitivity comprising extract of broussonetia kazinoki
KR20220064448A (en) 2020-11-11 2022-05-19 엠테라파마 주식회사 A composition for improving insulin sensitivity comprising mixture of herbal extracts of broussonetia kazinoki and juglans mandshurica

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101692889B1 (en) * 2014-01-09 2017-01-04 한국생명공학연구원 Composition comprising an extract or a fraction of Daphne kamtschatica for preventing or treating inflammatory diseases
KR101649047B1 (en) 2014-12-08 2016-08-17 숙명여자대학교산학협력단 Use of Kazinol C for treating or preventing cancer
KR102252129B1 (en) * 2020-11-10 2021-05-14 엠테라파마 주식회사 Composition for preventing or treating inflammatory bowel disease comprising herbal extract of broussonetia kazinoki

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Korean J. Soc. Food Sci. 15(3), 231~237 (1999.08.)*

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220029828A (en) 2020-08-28 2022-03-10 엠테라파마 주식회사 A composition for improving insulin sensitivity comprising extract of broussonetia kazinoki
KR20220064448A (en) 2020-11-11 2022-05-19 엠테라파마 주식회사 A composition for improving insulin sensitivity comprising mixture of herbal extracts of broussonetia kazinoki and juglans mandshurica

Also Published As

Publication number Publication date
KR20100029559A (en) 2010-03-17

Similar Documents

Publication Publication Date Title
KR101160943B1 (en) Health functional foods compositions for the prevention and amelioration of cancer containing the mixed extract of Phellinus linteus mycelium and cultured Panax Ginseng Cameyer as an active ingredient
KR101613693B1 (en) Composition for Prevention or Treatment of Skin Disease Comprising an Extract of Sargassum Horneri and Method of Preparing The Same
KR20120007275A (en) Composition comprising plants extract mixture for immune enhancement
KR102366919B1 (en) Functional health food composition for inhibiting muscle reduction comprising a mixed extract of mulberry twig, Eucommia bark, Acanthopanax, and black bean
KR101184666B1 (en) Composition for improving physiological activity of positive constitution
KR20180108331A (en) Method for improving periodontitis and alveolar bone loss of complex extracts of Moringa leaf and Eucommia Bark by anti-bacterial, antioxidant, anti-inflammatory, antioxidant effects and inhibition of alveolar bone loss
KR101045031B1 (en) A composition comprising fruits of Cudrania tricuspidata for immunopotentiating
KR101484021B1 (en) A Composition Comprising the extract of combined herbs including Curcuma Longa L. for immuno-stimulating activity
KR101039110B1 (en) A water composition comprising Broussonetia kazinoki Sieb. for immunopotentiating
KR20110127443A (en) Composition for anti-obesity and antioxidant comprising camellia japonica flower extract as active ingredient
JP5409439B2 (en) Composition for enhancing immune function, comprising Kouzo extract
KR20140017932A (en) Composition of diabetes-improving effective constituents by fermentation products of the trifoliate orange
KR101018403B1 (en) composition comprising the extract of soybean leaves for the prevention?delay or treatment of gout
KR100542876B1 (en) Composition comprising Schizandrae Fructus extract as an effective component for preventing and treating arthritis
KR101525877B1 (en) A composition for preventing wrinkle of skin and anti aging of skin
KR101207239B1 (en) A composition for the prevention and treatment of inflammatory disease comprising the fractions of Asparagus cochinchinensis as an active ingredient
KR100555904B1 (en) A herbal mixture extract of Pleurotus eryngii and Acanthopanacis Cortex and composition comprising the same for prevention and treatment of osteoporosis
KR101033003B1 (en) A composition comprising Broussonetiae Fructus for immunopotentiating
KR101456127B1 (en) A composition for increasing bone growth
KR101044717B1 (en) Composition containing extract of soybean leaves for prevention, delay or treatment of diabetes
KR101257909B1 (en) Pharmaceurtical compositions for the prevention or treatment of cancer containing the mixed extract of Phellinus linteus mycelium and cultured Panax Ginseng Cameyer as an active ingredient
KR101712889B1 (en) Pharmaceutical composition comprising Zingiber mioga extracts or its fractions for prevention and treatment of neurodegenerative disorders as an active ingredient
KR100533283B1 (en) Composition comprising extract of herbal mixture for prevention or treatment of osteoporosis
CN102188489A (en) Composition containing fructus broussonetiae extract for strengthening immune function
KR102185006B1 (en) A composition for improving, preventing and treating of asthma and vascular disease

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E90F Notification of reason for final refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20140316

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20160405

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20180530

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20190325

Year of fee payment: 9